Michael Craig - Mar 11, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
GC & Corporate Secretary
Signature
/s/Eric Halverson for Jeff Michael Craig, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
Mar 11, 2024
Transactions value $
-$2,602
Form type
4
Date filed
3/13/2024, 09:26 PM
Previous filing
Mar 11, 2024
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Sale -$949 -117 -2.73% $8.11* 4.16K Mar 11, 2024 Direct F1, F2
transaction NEUE Common Stock Sale -$543 -70 -1.68% $7.76* 4.09K Mar 12, 2024 Direct F1, F3
transaction NEUE Common Stock Sale -$1.11K -152 -3.71% $7.30* 3.94K Mar 13, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.85 and $8.38 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 and $8.10 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.11 and $7.52 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.